Y8P-46610-27687
3 vaccinations
3 coded responses
18 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 907 / CA
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Dose 1 — Pfizer-BioNTech
-
2021-03-20
Dose 2 — Pfizer-BioNTech
-
2021-04-09
Registered in v-safe
-
2021-04-09
Survey response — day 14, dose 2MedDRA: Fatigue, Pain — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: After my second dose I was extremely fatigued with body aches.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-06-19
- 2021-09-18
-
2022-01-05
Dose 3 — Moderna
-
2022-01-08
Survey response — days 1–6 daily, dose 3MedDRA: Injection site bruising, Injection site pain — Feeling: GoodFree text: Soreness and bruise at injection site.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-02-09
- 2022-02-16
- 2022-07-06
-
2023-01-05
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-20 | Pfizer-BioNTech | |
| 3 | 2022-01-05 | Moderna | No |
Free text
Release 7 — day 14, dose 2
Symptoms: After my second dose I was extremely fatigued with body aches.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Soreness and bruise at injection site.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release